Womans Health

Dr Oz Talks about Cancer and Food on TV Show

alt text

(Best Syndication News) There have been many cancer-fighting advances over the past few years. The newest approach is the “whole body” system. It combines surgery, chemotherapy and radiation with less than “traditional” therapies that were once dismissed by the medical industry.

These non-traditional therapies include acupuncture, pain and stress management along with nutrition. Some patients may find relief with yoga.

Doctor Mehmet Oz brought three cancer experts onto his show Friday. Doctor Steven Standiford, MD, surgeon at the Cancer Treatment Centers of America, Doctor Deborah Axelrod, MD, a director at the NYU Cancer Institute, and nutritionist Rachel Beller, RD spoke to Dr Oz Friday.

Women taking Topamax topiramate prescription drug during pregnancy increases risk for Cleft Birth Defects

Women taking Topamax topiramate prescription drug during pregnancy increases risk for Infant Birth Defects

Best Syndication News

(Best Syndication News) - Women taking anti-convulsant medication, Topamax or the generic topiramate, during pregnancy have an increased risk for their baby to be born with birth defects in the mouth. These birth defects include cleft lip and cleft palate problems said the US Food and Drug Administration (FDA).

The North American Antiepileptic Drug (AED) Pregnancy Registry collected the data which showed the increased risk of oral clefts in babies that had mothers who had taken topiramate during the first trimester of the pregnancy. A single therapy exposure to the infant during gestation to the topiramate drug was 1.4 percent occurrence of developing an oral cleft birth defect compared with 0.38 percent – 0.55 percent of other anti-eplileptic drugs that were exposed to infants. Mothers that do not take any anti-convulsant medication had only a 0.07 percent prevalence of a cleft birth defect.

Breast implants showed possible increased risk of rare cancer says FDA

Breast implants showed possible increased risk of rare cancer says FDA

Best Syndication News

(Best Syndication News) - The US Food and Drug Administration (FDA) announced a potential associated increased risk of saline and silicone gel-filled breast implants and a rare anaplastic large cell lymphoma cancer. The increased risk is small said the FDA, but at the same time is significant.

The FDA is asking health care professionals to report any women that have been diagnosed with anaplastic large cell lymphoma cancer so they can further evaluate this potential risk for ALCL cancer and breast implants. Because of the potential cancer risk, the FDA will be working with breast implant manufacturing companies to include notices of the cancer risk.

The National Cancer Institute said that ALCL is diagnosed in 1 out of 500,000 women each year. ALCL found in breast tissue is diagnosed 3 out of every 100 million in women without breast implants every year.

Middle age women reduced cardiovascular disease by lowering high blood pressure

Middle age women reduced cardiovascular disease by lowering high blood pressure

Best Syndication News

(Best Syndication News) - Previous research has found that having high blood pressure is associated with increased risk of heart disease. However a recent study with middle-aged women showed that by lowering high blood pressure they also reduced their risk for developing cardiovascular disease more so than the men in the study. The research findings were reported in the Hypertension: Journal of the American Heart Association.

Cardiovascular disease includes stroke, heart attack, and heart failure. This large study involved researchers from 11 countries throughout Europe, Asia, and South America who took part of the International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO). This large data collection included 9,357 adults averaging 53 year old with 47 percent being women from countries around the world. The participants were studied over 11 years or longer for cardiovascular disease and measurements of systolic blood pressure.

Osteoporosis Bisphosponate Medication has increased risk of Thigh Bone Fracture

Osteoporosis Bisphosponate Medication has increased risk of Thigh Bone Fracture

Best Syndication News

(Best Syndication News) - The US Food and Drug Administration (FDA) is adding a warning to the labels of bisphosponate medications because of a risk for thigh bone fractures in patients that take this medication for the long term.

Bisphosphonates prescription drugs help overall to reduce osteoporotic bone fractures. People with thinning bones or osteoporosis take bisphosphonates to prevent fractures. The FDA says that they are not sure why, but there seems to be a a higher incidence of a serious thigh bone fracture. The FDA said that they do not know how long a person can take Bisphosphonates and they suggest that these thigh fractures may be with those patients taking the medication for more than five years.

This warning came after the FDA started investigating atypical femur fractures with people taking bisphosphonates at the beginning of this year. The FDA is still evaluating data on the safety on how effective bisphosphonate are and may announce more information in the future.

Syndicate content
Share/Save/Bookmark

      

Post to Facebook

Important: The material on Best Syndication is for informational purposes only and is not meant to be advice. Authors may have or will receive monetary compensation from the company's product/s mentioned. You should always seek professional advice before making any legal, financial or medical decisions and this website cannot substitute or replace any trained professional consultation.
Use of this site means that you agree to our TERMS OF SERVICE

Advertise On This Site
Copyright © 2006-2015 By Best Syndication All Rights Reserved